UBAM - Dr. Ehrhardt German Equity (AC)
As at: 22/05/2013
| ISIN: | LU0087798301 |
| WKN: | 921807 |
| Bloomberg: | SCEFGRE LX |
| Reuters: | LU0087798301.LUF |
| Asset Class: | Equity Funds German Blue Chips |
| Investment Company: | Union Bancaire Privée, UBP SA |
| Fund Manager: | Union Bancaire Privée, Sub-Manager DJE Kapital AG |
| Risk Category: | 3 |
| Type of Share: | Accumulation |
| Financial Year: | 01/01 - 31/12 |
| Launch Date: | 25/05/1998 |
| Fund Size (30/04/2013): | 71.67m EUR |
| TER p.a. (31/12/2012): | 2.09% |
| Reference Index: | 100% DAX INDEX |
Sub-Manager
Dr. Jens Ehrhardt
| Initial Charge: | 5.25% |
| Management Fee p.a.: | 0.40% |
| Custodian Fee p.a.: | 0.20% |
| Advisory Fee p.a.: | 1.10% |
Investment Strategy
The fund focuses its investments on German equities from all segments, with the majority of investments being made in financially solid German large caps. Selected small and medium-size companies are also part of the investment mix. The fund managers place particular emphasis on intensive contact with the company. Additionally, up to 10% of the fund's assets may be invested outside Germany. The fund is actively managed and the cash reserves can be dynamically managed depending on the market situation.
| Morningstar RatingTMOverall *: |  |
| €uro Fund Award 2011: | 3rd Place, German Equity Funds, 10 years, Germany |
Monthly Fund Manager's Commentary
In April the international stock markets registered a moderate profit of 0.22 % compared to the MSCI Euro. The European markets performed better, measured by the Stoxx 600 (+1.00%) or the DAX (+1.52%). Due to the weak US Dollar (-2.56 %), the only possibility for an Euro investor to archive a profit with US ( S&P 500 0,79%) or Hong Kong equities (HIS -0.61%) was currency hedging. Since at the beginning of the month the inflows of fresh investors money towards USA and Japan continued, by month end the first ETF outflows were registered since 22 weeks. Japan, on the other side, attracted further money and the Nikkei archived a five-year high. The economic data in the US cooled down. After a weak purchasing manager index at the beginning of the month, poor US job data forced a Euro eruption. The Japanese Yen, however, dropped on particular days 3.47 per cent, after the announcement of the BoJ to extend the bond purchasing program even to longer maturities. In China negative news predominated: a weak GDB, unpleasant industrial production figures and purchasing manager index. But also in Germany the ifo- a measure of business sentiment - declined again. The ECB prepared a rate cut by explicitly pointing out the weakness of the European economy. The prices adapted accordingly. The IMF and international finance politicians ask for economic stimulation not only money printing, but the Bundesbank still refuses the purchase of government bonds by the ECB. At least one of the highest risks for the recovering of the Eurozone is banned by forming the Italian government. The reporting season in the US started mixed and did not offer any special impulses. The attacks in the US, the bird flu in China or the North Korean conflict only affected the market shortly. Very disappointing was the crash of the gold price and gold equities. After record high ETF outflows during the previous months, the gold price lost again 7.93 per cent. Because of the expected rebalancing, the middle term outlooks for equities are still attractive from the valuation point of view. Altogether the trends are sound and despite respectively because of the slowdown in economic signals (monetary and fiscal stimuli more likely) viewing the year 2013 the fund management expects good opportunities in setbacks especially for high yield shares.
Legal Information / Disclaimer:
Figures subject to revision by the auditors on the reporting dates. The published information does not constitute investment advice or a recommendation, but only provides a brief summary of the key features of the fund. The current sales documents (Key Investor Information Document, prospectus, annual report and – if the annual report is older than eight months – the semi-annual report) for the respective investment funds form the sole basis for the purchase of securities. The sales documents are available at no charge at the respective fund company, the distribution company or at www.dje.de.
All data and estimates are indicative and may change at any time. This information is based on our assessment of current legal and tax regulations. The data were carefully compiled, but no guarantee can be given for the accuracy of such information. All data are subject to change.
The performance is calculated using the BVI (Bundesverband Investment und Asset Management e.V.) method, i.e. without taking into account the subscription fee. Individual expenses such as fees, commissions and other charges are not taken into account in the data and would have a detrimental effect on the performance if they were. The subscription fees payable reduce the invested capital as well as the performance depicted. Data on past performance are not a reliable indicator of future performance.
The tax treatment depends on the individual circumstances of the investor and may be subject to change. Please see the prospectus for more detailed tax information.
In connection with brokering fund units, the Dr. Jens Ehrhardt Group and its distribution partners may receive reimbursements from costs charged to the funds by the investment companies in accordance with the respective prospectuses.
The units of this fund that are issued may only be sold or offered for sale in jurisdictions in which such offer or sale is permitted. Therefore the units of this fund may not be offered for sale or sold in the USA, or offered for sale or sold to or for the account of US citizens or US persons resident in the USA.
This document and the information it contains may not be distributed in the USA. The distribution and publication of this document and the offer or sale of units may also be subject to restrictions in other jurisdictions.
*) © 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.